(firstQuint)Exemestane in Advanced and Recurrent Endometrial Carcinoma.

 Patients With Advanced or recurrent endometrial cancer of endometrioid type were treated With Exemestane tablets 25 mg daily.

 Patients were grouped according to estrogen receptor status.

.

 Exemestane in Advanced and Recurrent Endometrial Carcinoma@highlight

A phase II study of Exemestane in Advanced or recurrent endometrial carcinoma Hypothesis: Treatment With Exemestane can give a response rate of at least 30%